These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32998989)

  • 41. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes.
    Elleri D; Allen JM; Biagioni M; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Acerini CL; Dunger DB; Hovorka R
    Pediatr Diabetes; 2012 Sep; 13(6):449-53. PubMed ID: 22817340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic.
    Berget C; Thomas SE; Messer LH; Thivener K; Slover RH; Wadwa RP; Alonso GT
    J Diabetes Sci Technol; 2020 Mar; 14(2):290-296. PubMed ID: 30862242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of two carbohydrate intake strategies to improve glucose control during exercise in adolescents and adults with type 1 diabetes.
    Goulet-Gélinas L; Saade MB; Suppère C; Fortin A; Messier V; Taleb N; Tagougui S; Shohoudi A; Legault L; Henderson M; Rabasa-Lhoret R
    Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1238-1246. PubMed ID: 33632598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.
    Biagi L; Hirata Bertachi A; Conget I; Quirós C; Giménez M; Ampudia-Blasco FJ; Rossetti P; Bondia J; Vehí J
    J Diabetes Sci Technol; 2017 Nov; 11(6):1089-1095. PubMed ID: 28633537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system.
    Ekhlaspour L; Forlenza GP; Chernavvsky D; Maahs DM; Wadwa RP; Deboer MD; Messer LH; Town M; Pinnata J; Kruse G; Kovatchev BP; Buckingham BA; Breton MD
    Pediatr Diabetes; 2019 Sep; 20(6):759-768. PubMed ID: 31099946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: are current recommendations effective?
    Gingras V; Desjardins K; Smaoui MR; Savard V; Messier V; Haidar A; Legault L; Rabasa-Lhoret R
    Acta Diabetol; 2018 Mar; 55(3):227-231. PubMed ID: 29224132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes.
    Galderisi A; Sherr JL
    Pediatr Ann; 2019 Aug; 48(8):e311-e318. PubMed ID: 31426099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of daily glycemic profiles in well controlled children with type 1 diabetes mellitus using a continuous glucose monitoring system.
    Tucholski K; Deja G; Skała-Zamorowska E; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2009; 15(1):29-33. PubMed ID: 19454186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Automated overnight closed-loop glucose control in young children with type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Mangat JS; Larsen AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2011 Apr; 13(4):419-24. PubMed ID: 21355719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial.
    Nimri R; Bratina N; Kordonouri O; Avbelj Stefanija M; Fath M; Biester T; Muller I; Atlas E; Miller S; Fogel A; Phillip M; Danne T; Battelino T
    Diabetes Obes Metab; 2017 Apr; 19(4):553-561. PubMed ID: 27981804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
    Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
    Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized Controlled Trial of Mobile Closed-Loop Control.
    Kovatchev B; Anderson SM; Raghinaru D; Kudva YC; Laffel LM; Levy C; Pinsker JE; Wadwa RP; Buckingham B; Doyle FJ; Brown SA; Church MM; Dadlani V; Dassau E; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Lum J; Beck RW;
    Diabetes Care; 2020 Mar; 43(3):607-615. PubMed ID: 31937608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis.
    Pease A; Lo C; Earnest A; Kiriakova V; Liew D; Zoungas S
    Diabetes Care; 2020 Aug; 43(8):1967-1975. PubMed ID: 32669412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R
    Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipohypertrophy Effect on Glycemic Profile in an Adult With Type 1 Diabetes Using Scanned Continuous Glucose Monitoring.
    Oriot P; Hermans MP
    J Diabetes Sci Technol; 2020 Mar; 14(2):500-501. PubMed ID: 31847568
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of i-Port Advance system on patients satisfaction and glycemic control among patients with type 1 diabetes in Saudi Arabia.
    Al Hayek AA; Robert AA; Al Dawish MA
    Diabetes Metab Syndr; 2021; 15(3):747-751. PubMed ID: 33823329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Modular Safety System for an Insulin Dose Recommender: A Feasibility Study.
    Liu C; Avari P; Leal Y; Wos M; Sivasithamparam K; Georgiou P; Reddy M; Fernández-Real JM; Martin C; Fernández-Balsells M; Oliver N; Herrero P
    J Diabetes Sci Technol; 2020 Jan; 14(1):87-96. PubMed ID: 31117804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults.
    Sherr JL
    Diabetes Care; 2018 Aug; 41(8):1572-1578. PubMed ID: 29936422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Effect of Control IQ Hybrid Closed Loop Technology on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related Diabetes.
    Scully KJ; Palani G; Zheng H; Moheet A; Putman MS
    Diabetes Technol Ther; 2022 Jun; 24(6):446-452. PubMed ID: 35020476
    [No Abstract]   [Full Text] [Related]  

  • 60. Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI).
    Riddell MC; Li Z; Gal RL; Calhoun P; Jacobs PG; Clements MA; Martin CK; Doyle Iii FJ; Patton SR; Castle JR; Gillingham MB; Beck RW; Rickels MR;
    Diabetes Care; 2023 Apr; 46(4):704-713. PubMed ID: 36795053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.